Similarities between Index of oncology articles and Ondansetron
Index of oncology articles and Ondansetron have 14 things in common (in Unionpedia): Anaphylaxis, Blinded experiment, Chemotherapy, Clinical trial, Heart failure, Intramuscular injection, Intravenous therapy, Liver, Metoclopramide, Open-label trial, Parkinson's disease, Radiation therapy, Randomized controlled trial, Serotonin.
Anaphylaxis
Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.
Anaphylaxis and Index of oncology articles · Anaphylaxis and Ondansetron ·
Blinded experiment
A blind or blinded-experiment is an experiment in which information about the test is masked (kept) from the participant, to reduce or eliminate bias, until after a trial outcome is known.
Blinded experiment and Index of oncology articles · Blinded experiment and Ondansetron ·
Chemotherapy
Chemotherapy (often abbreviated to chemo and sometimes CTX or CTx) is a type of cancer treatment that uses one or more anti-cancer drugs (chemotherapeutic agents) as part of a standardized chemotherapy regimen.
Chemotherapy and Index of oncology articles · Chemotherapy and Ondansetron ·
Clinical trial
Clinical trials are experiments or observations done in clinical research.
Clinical trial and Index of oncology articles · Clinical trial and Ondansetron ·
Heart failure
Heart failure (HF), often referred to as congestive heart failure (CHF), is when the heart is unable to pump sufficiently to maintain blood flow to meet the body's needs.
Heart failure and Index of oncology articles · Heart failure and Ondansetron ·
Intramuscular injection
Intramuscular (also IM or im) injection is the injection of a substance directly into muscle.
Index of oncology articles and Intramuscular injection · Intramuscular injection and Ondansetron ·
Intravenous therapy
Intravenous therapy (IV) is a therapy that delivers liquid substances directly into a vein (intra- + ven- + -ous).
Index of oncology articles and Intravenous therapy · Intravenous therapy and Ondansetron ·
Liver
The liver, an organ only found in vertebrates, detoxifies various metabolites, synthesizes proteins, and produces biochemicals necessary for digestion.
Index of oncology articles and Liver · Liver and Ondansetron ·
Metoclopramide
Metoclopramide is a medication used mostly for stomach and esophageal problems.
Index of oncology articles and Metoclopramide · Metoclopramide and Ondansetron ·
Open-label trial
An open-label trial, or open trial, is a type of clinical trial in which both the researchers and participants know which treatment is being administered.
Index of oncology articles and Open-label trial · Ondansetron and Open-label trial ·
Parkinson's disease
Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.
Index of oncology articles and Parkinson's disease · Ondansetron and Parkinson's disease ·
Radiation therapy
Radiation therapy or radiotherapy, often abbreviated RT, RTx, or XRT, is therapy using ionizing radiation, generally as part of cancer treatment to control or kill malignant cells and normally delivered by a linear accelerator.
Index of oncology articles and Radiation therapy · Ondansetron and Radiation therapy ·
Randomized controlled trial
A randomized controlled trial (or randomized control trial; RCT) is a type of scientific (often medical) experiment which aims to reduce bias when testing a new treatment.
Index of oncology articles and Randomized controlled trial · Ondansetron and Randomized controlled trial ·
Serotonin
Serotonin or 5-hydroxytryptamine (5-HT) is a monoamine neurotransmitter.
Index of oncology articles and Serotonin · Ondansetron and Serotonin ·
The list above answers the following questions
- What Index of oncology articles and Ondansetron have in common
- What are the similarities between Index of oncology articles and Ondansetron
Index of oncology articles and Ondansetron Comparison
Index of oncology articles has 1711 relations, while Ondansetron has 72. As they have in common 14, the Jaccard index is 0.79% = 14 / (1711 + 72).
References
This article shows the relationship between Index of oncology articles and Ondansetron. To access each article from which the information was extracted, please visit: